MYOS Corporation Announces Corporate Name Change to MYOS

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc.

CEDAR KNOLLS, NJ--(Marketwired - Mar 22, 2016) - MYOS Corporation ("MYOS" or the "Company") ( NASDAQ : MYOS ), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve human muscle health and performance, announced today that it is changing its corporate name to MYOS RENS Technology Inc. The name change reflects the important alignment between MYOS, a leader in bionutrition and biotherapeutic products designed to improve the health and performance of muscle tissue, and affiliates of RENS Technology Inc., including RENS Agriculture Science & Technology Inc., a leader in food freezing technology in China and an innovator in the science of preserving the integrity of food-derived proteins. The Company's common stock will continue to be listed on the Nasdaq Capital Market under the symbol "MYOS." 

Dr. Robert Hariri, Chairman of the Board of Directors, commented, "The new name -- MYOS RENS Technology Inc. -- emphasizes our objective to globalize the powerful products developed by MYOS. As a company rooted in science and technology, we are committed to delivering breakthrough products globally that aim to improve the health and performance of muscle tissue."

About MYOS Corporation MYOS is an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS is the owner of Fortetropin®, the first clinically proven natural myostatin reducing agent. Myostatin is a natural regulatory protein, which inhibits muscle growth and recovery. Medical literature suggests that lowering myostatin levels has many potential health benefits including increased muscle mass, healthy weight management, improved energy levels, stimulation of muscle healing as well as treating sarcopenia, a condition of age-related loss of muscle mass. To discover why MYOS is known as "The Muscle Company,"™ visit www.myoscorp.com

About RENS Agriculture RENS Agriculture was founded by Mr. Ren Ren and has substantial investments in the food and agricultural sectors in China. RENS Agriculture's proprietary "fresh freezing and preservation technology" is a leading food freezing technology that not only extends the refrigerator life of foods but also preserves their flavor and texture. As food safety is a major concern in China, which also brings additional market opportunities, RENS Agriculture has focused on investing in a number of "safe foods industrial parks" in China. These parks have food freezing facilities that use RENS Agriculture's technology to freeze the foods produced by the farms inside and around the park and directly deliver these frozen foods to supermarkets and consumers. RENS Agriculture's goal is to deliver safe quality foods to millions of consumers in China. RENS Agriculture has invested in a bamboo roots processing facility in Hangzhou, fish farms in Zhoushan, tea oil plants in Jiangxi, and frozen foods processing centers in Beijing and Nanjing. RENS Agriculture also cooperated with Chilean fishing industry to import salmon and is negotiating with Australian farmers to import beef and lamb into China.

Forward-Looking Statements Any statements in this release that are not historical facts are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to the successful continued research of Fortetropin® and its effects on myostatin levels, inflammatory cytokine levels and cholesterol levels, the successful launch and customer demand for our Rē Muscle Health™ and other products, the closing of the second and third tranches of the recent financing with RENS (the "Financing"), the continued growth of repeat purchases, market acceptance of our existing and future products, the ability to create new products through research and development, growth in our revenue, including the successful expansion through the distribution efforts with RENS, the successful entry into new markets including the age management market, the ability to collect our accounts receivable from our distributors, our ability to raise capital to fund continuing operations, including closing the second and third tranches of the Financing and through the exercise of the warrants issued in the Financing, the ability to attract additional investors and increase shareholder value, the ability to generate the forecasted revenue stream and cash flow from sales of Fortetropin® and Rē Muscle Health™, the ability to achieve a sustainable profitable business, the effect of economic conditions, the ability to protect our intellectual property rights, the ability to maintain and expand our manufacturing capabilities including finding suitable manufacturing partners in China and reduce the costs of our products, the ability to comply with NASDAQ's continuing listing standards, the ability to acquire suitable acquisition targets, competition from other providers and products, risks in product development, and other factors discussed from time to time in our Securities and Exchange Commission filings. We undertake no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Contact: Joseph DosSantos Chief Financial Officer (973) 509-0444 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 257

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 15

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
TIER IV Simplifies Autonomous Driving with CARLA 1.0

Updated Category News Views 138

No More Detours in Autonomous Development Ever messed with a puzzle that just won't fit until suddenly, it clicks? That's what TIER IV just pulled off with their latest work on CARLA 1.0, the open-source simulator. There's no more mucking about with that separate Python-based bridge to get things communicating—now we're talking native Autoware support. A direct line to...

Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 68

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 46

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 297

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 0

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 130

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
Ideas Abu Dhabi Puts Water Innovation on Stage

Updated Category News Views 25

Water rarely gets the spotlight until a pipe fails, a harvest shrinks, or a city starts rationing. That is why the agenda around Ideas Abu Dhabi at the 2026 UN Water Conference deserves more than the usual polite nod given to conference programming. From 7 to 10 December in Abu Dhabi, this is shaping up as a public-facing attempt to connect a hard physical problem with...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 26

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading

Top 5 Most Recently Viewed Articles

HydrogenPro ASA Reports Strong Q4 2024 Financial Insights

Updated Category News Views 205

HydrogenPro ASA's Financial Results Overview HydrogenPro ASA (OSE: HYPRO) recently revealed its remarkable financial outcomes for the fourth quarter of 2024, showcasing a solid performance despite the challenges faced in the industry. This quarter highlights the company’s resilience and strengthens its position in the global hydrogen market. Key Achievements in Q4 2024...

Continue Reading
Angioplasty Balloons Market: $3.6B by 2033? Unpack the Growth!

Updated Category News Views 174

February 18, 2026—mark it down: the angioplasty balloons market is gearing up to swell from a cool $2.6 billion in 2023 to a whopping $3.6 billion by 2033 at a steady CAGR of 3.4%. Why? Well, take your pick: rising cardiovascular disease prevalence, a geriatric boom, and increasingly tech-savvy procedures are all fueling this surge. What’s Pumping Up Growth?...

Continue Reading
Norges Bank Transitions to Major Shareholder in NKT A/S

Updated Category News Views 175

Significant Shareholding Changes in NKT A/S In a recent announcement that has stirred interest in the investment community, it has come to light that Norges Bank has increased its holdings in NKT A/S. This announcement is significant as it illustrates the dynamic changes within major shareholding structures in public companies. Understanding the Acquisition NKT A/S has...

Continue Reading
Novo Nordisk Strengthens Shareholder Value with Buyback Plan

Updated Category News Views 103

Introduction to Novo Nordisk's Share Repurchase Program Leading healthcare company Novo Nordisk has embarked on an ambitious share repurchase program to strengthen its shareholder value. This initiative, aligning with European financial regulations, showcases the company's commitment to enhancing shareholder returns. The overall plan involves a substantial repurchase...

Continue Reading
Unlocking Potential: Monthly Dividend Strategies for Retirement

Updated Category News Views 189

Maximizing Monthly Income for Retirement Imagine enjoying monthly dividends that accumulate annual yields ranging from 7.2% to 15.4%. It’s enticing, especially for those looking for a steady stream of income during retirement. With the current market filled with uncertainty, many investors are skittish and hesitant to put their money into traditional investments. This...

Continue Reading